Clearside Biomedical (CLSD) is Initiated by Needham to Buy, Price Target at $16

Clearside Biomedical (CLSD) was Initiated by Needham to “Buy” and the brokerage firm has set the Price Target at $16. Needham advised their investors in a research report released on Jun 28, 2016.

Many Wall Street Analysts have commented on Clearside Biomedical. Wedbush Initiated Clearside Biomedical on Jun 27, 2016 to “Outperform”, Price Target of the shares are set at $28.Stifel Initiated Clearside Biomedical on Jun 27, 2016 to “Buy”, Price Target of the shares are set at $13.

Clearside Biomedical

Leave a Reply

Clearside Biomedical - Is it time to Sell?

Top Brokerage Firms are advising their investors on Clearside Biomedical. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.